Influence of methylphenidate on brain development--an update of recent animal experiments.

Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G (2006)
Behav Brain Funct 2(1): 2.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA
DOI
URN
urn:nbn:de:0070-pub-16660621
Autor*in
Grund, Thorsten; Lehmann, Konrad; Bock, Nathalie; Rothenberger, Aribert; Teuchert-Noodt, GertraudUniBi
Einrichtung
Fakultät für Biologie
Abstract / Bemerkung
Methylphenidate (MPH) is the most commonly used drug to treat attention deficit/hyperactivity disorder (ADHD) in children effectively and safely. In spite of its widespread application throughout one of the most plastic and sensitive phases of brain development, very little is known to date about its long-term effects on brain structure and function. Hence, this short review updates the influence of MPH on brain development, since recent human and animal studies suggest that MPH alters the dopaminergic system with long-term effects beyond the termination of treatment.Animal studies imply that the effects of MPH may depend on the neural responder system: Whereas structural and functional parameters are improved by MPH in animals with psychomotor impairments, they remain unaltered or get worse in healthy controls. While recent behavioural studies do not fully support such a differential effect of MPH in ADHD, the animal studies certainly prompt for further investigation of this issue. Furthermore, the abuse of MPH, when (rarely) intravenously applied, may even impair the maturation of dopaminergic fibres in subcortical brain areas. This argues for careful clinical assessment and diagnostics of ADHD symptomatology not only in conjunction with the prescription of MPH. Hence, one should be assured that MPH is only given to children with clear ADHD symptomatology leading to psychosocial impairment. The animal data suggest that under these conditions MPH is supportive for brain development and the related behaviour in children with ADHD.
Erscheinungsjahr
2006
Zeitschriftentitel
Behav Brain Funct
Band
2
Ausgabe
1
Art.-Nr.
2
ISSN
1744-9081
Page URI
https://pub.uni-bielefeld.de/record/1666062

Zitieren

Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G. Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct. 2006;2(1): 2.
Grund, T., Lehmann, K., Bock, N., Rothenberger, A., & Teuchert-Noodt, G. (2006). Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct, 2(1), 2. https://doi.org/10.1186/1744-9081-2-2
Grund, Thorsten, Lehmann, Konrad, Bock, Nathalie, Rothenberger, Aribert, and Teuchert-Noodt, Gertraud. 2006. “Influence of methylphenidate on brain development--an update of recent animal experiments.”. Behav Brain Funct 2 (1): 2.
Grund, T., Lehmann, K., Bock, N., Rothenberger, A., and Teuchert-Noodt, G. (2006). Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct 2:2.
Grund, T., et al., 2006. Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct, 2(1): 2.
T. Grund, et al., “Influence of methylphenidate on brain development--an update of recent animal experiments.”, Behav Brain Funct, vol. 2, 2006, : 2.
Grund, T., Lehmann, K., Bock, N., Rothenberger, A., Teuchert-Noodt, G.: Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct. 2, : 2 (2006).
Grund, Thorsten, Lehmann, Konrad, Bock, Nathalie, Rothenberger, Aribert, and Teuchert-Noodt, Gertraud. “Influence of methylphenidate on brain development--an update of recent animal experiments.”. Behav Brain Funct 2.1 (2006): 2.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Volltext(e)
Name
Access Level
OA Open Access
Zuletzt Hochgeladen
2019-09-06T08:48:06Z
MD5 Prüfsumme
9ea8be303ca725eeb60f83a4808bcbad


32 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.
Busardò FP, Kyriakou C, Cipolloni L, Zaami S, Frati P., Curr Neuropharmacol 14(1), 2016
PMID: 26813119
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.
Thanos PK, Robison LS, Steier J, Hwang YF, Cooper T, Swanson JM, Komatsu DE, Hadjiargyrou M, Volkow ND., Pharmacol Biochem Behav 131(), 2015
PMID: 25641666
Adolescent exposure to methylphenidate impairs serial pattern learning in the serial multiple choice (SMC) task in adult rats.
Rowan JD, McCarty MK, Kundey SM, Osburn CD, Renaud SM, Kelley BM, Matoushek AW, Fountain SB., Neurotoxicol Teratol 51(), 2015
PMID: 26225921
Withdrawal effect of chronic amphetamine exposure during adolescence on complex maze performance.
Krall DM, Lim SL, Cooper AM, Burleson PW, Rhoades DJ, Jacquemin SJ, Willmore DC, Spears FM, Willmore CB., Addict Biol 19(4), 2014
PMID: 23374198
The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.
Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L., BMC Psychiatry 14(), 2014
PMID: 24552282
What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).
Kovshoff H, Vrijens M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ, Danckaerts M., Eur Child Adolesc Psychiatry 22(9), 2013
PMID: 23455602
Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
Dela Peña I, Kim BN, Han DH, Kim Y, Cheong JH., Arch Pharm Res 36(4), 2013
PMID: 23471559
Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.
Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J., J Clin Psychiatry 74(9), 2013
PMID: 24107764
Acute dose-related differential effects of methylphenidate on murine cystometric parameters.
Choi SH, Cho YS, Cho ST, Lee T, Kim KH., Int Neurourol J 17(4), 2013
PMID: 24466462
Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons.
Urban KR, Waterhouse BD, Gao WJ., Biol Psychiatry 72(10), 2012
PMID: 22609367
Age and genetic strain differences in response to chronic methylphenidate administration.
Yang PB, Cuellar DO, Swann AC, Dafny N., Behav Brain Res 218(1), 2011
PMID: 21111006
Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
Sagvolden T., Behav Brain Funct 7(), 2011
PMID: 21450079
Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes.
Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M, Holsboer F, Rein T, Zschocke J., Neuropsychopharmacology 35(3), 2010
PMID: 19924110
Identifying the neurobiology of altered reinforcement sensitivity in ADHD: a review and research agenda.
Luman M, Tripp G, Scheres A., Neurosci Biobehav Rev 34(5), 2010
PMID: 19944715
Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N., Neuroscience 167(4), 2010
PMID: 20211696
Methylphenidate and if-then plans are comparable in modulating the P300 and increasing response inhibition in children with ADHD.
Paul-Jordanov I, Bechtold M, Gawrilow C., Atten Defic Hyperact Disord 2(3), 2010
PMID: 21432597
Development of 5-HT transporter density and long-term effects of methylphenidate in an animal model of ADHD.
Roessner V, Manzke T, Becker A, Rothenberger A, Bock N., World J Biol Psychiatry 10(4 pt 2), 2009
PMID: 19172439
Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain.
Banerjee PS, Aston J, Khundakar AA, Zetterström TS., Eur J Neurosci 29(3), 2009
PMID: 19222557
Aberrant functional activation in school age children at-risk for mathematical disability: a functional imaging study of simple arithmetic skill.
Davis N, Cannistraci CJ, Rogers BP, Gatenby JC, Fuchs LS, Anderson AW, Gore JC., Neuropsychologia 47(12), 2009
PMID: 19410589
Effect of postnatal methamphetamine trauma and adolescent methylphenidate treatment on adult hippocampal neurogenesis in gerbils.
Schaefers AT, Teuchert-Noodt G, Bagorda F, Brummelte S., Eur J Pharmacol 616(1-3), 2009
PMID: 19540225
Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?
Lee MJ, Yang PB, Wilcox VT, Burau KD, Swann AC, Dafny N., Neuropharmacology 57(3), 2009
PMID: 19540860
The neural development of an abstract concept of number.
Cantlon JF, Libertus ME, Pinel P, Dehaene S, Brannon EM, Pelphrey KA., J Cogn Neurosci 21(11), 2009
PMID: 19016605
l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
Sagvolden T, Xu T., Behav Brain Funct 4(), 2008
PMID: 18215285
Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats.
Vendruscolo LF, Izídio GS, Takahashi RN, Ramos A., Behav Pharmacol 19(1), 2008
PMID: 18195591
Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils.
Brummelte S, Grund T, Moll GH, Teuchert-Noodt G, Dawirs RR., J Negat Results Biomed 7(), 2008
PMID: 18485211
Methylphenidate increases creatine kinase activity in the brain of young and adult rats.
Scaini G, Fagundes AO, Rezin GT, Gomes KM, Zugno AI, Quevedo J, Streck EL., Life Sci 83(23-24), 2008
PMID: 18938183
Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder.
Rüsch N, Weber M, Il'yasov KA, Lieb K, Ebert D, Hennig J, van Elst LT., Neuroimage 35(2), 2007
PMID: 17289404
Methylphenidate treatment recovers stress-induced elevated dendritic spine densities in the rodent dorsal anterior cingulate cortex.
Zehle S, Bock J, Jezierski G, Gruss M, Braun K., Dev Neurobiol 67(14), 2007
PMID: 17874461
Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study.
Konrad K, Neufang S, Fink GR, Herpertz-Dahlmann B., J Am Acad Child Adolesc Psychiatry 46(12), 2007
PMID: 18030085
Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?
Roessner V, Walitza S, Riederer F, Hünnerkopf R, Rothenberger A, Gerlach M, Moser A., Behav Brain Funct 3(), 2007
PMID: 18070346
Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view.
Schneider M, Retz W, Coogan A, Thome J, Rösler M., Eur Arch Psychiatry Clin Neurosci 256 Suppl 1(), 2006
PMID: 16977550
Postnatal development of dopamine innervation in the amygdala and the entorhinal cortex of the gerbil (Meriones unguiculatus).
Brummelte S, Teuchert-Noodt G., Brain Res 1125(1), 2006
PMID: 17112487

120 References

Daten bereitgestellt von Europe PubMed Central.

ADHD – beyond core symptoms. Not only a European perspective
Rothenberger A, Dopfner M, Sergeant J, Steinhausen HC., 2004
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn.
Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, Mrazek DA, Jacobsen SJ., Arch Pediatr Adolesc Med 156(3), 2002
PMID: 11876664
Attention-deficit hyperactivity disorder.
Biederman J, Faraone SV., Lancet 366(9481), 2005
PMID: 16023516
Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade.
Nigg JT., Biol. Psychiatry 57(11), 2005
PMID: 15950017
Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways.
Sonuga-Barke EJ., Biol. Psychiatry 57(11), 2005
PMID: 15949993
Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder.
Viggiano D, Vallone D, Ruocco LA, Sadile AG., Neurosci Biobehav Rev 27(7), 2003
PMID: 14624812
Animal models of attention-deficit hyperactivity disorder.
Russell VA, Sagvolden T, Johansen EB., Behav Brain Funct 1(), 2005
PMID: 16022733
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC, Nutt DJ., Curr Opin Pharmacol 5(1), 2005
PMID: 15661631
EINAQ -- a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems.
Rothenberger A, Danckaerts M, Dopfner M, Sergeant J, Steinhausen HC., Eur Child Adolesc Psychiatry 13 Suppl 1(), 2004
PMID: 15322954
Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats.
Spear LP, Brake SC., Dev Psychobiol 16(2), 1983
PMID: 6339302
Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens.
Teicher MH, Andersen SL, Hostetter JC Jr., Brain Res. Dev. Brain Res. 89(2), 1995
PMID: 8612321
Maturation of the dopamine innervation during postnatal development of the prefrontal cortex in gerbils (Meriones unguiculatus). A quantitative immunocytochemical study.
Dawirs RR, Teuchert-Noodt G, Czaniera R., J Hirnforsch 34(3), 1993
PMID: 8270782
Development of the dopaminergic innervation in the prefrontal cortex of the rat.
Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB., J. Comp. Neurol. 269(1), 1988
PMID: 3361004
Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT.
Froimowitz M, Patrick KS, Cody V., Pharm. Res. 12(10), 1995
PMID: 8584475
Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters
Gatley SJ, Pan DF, Chen RY, Chaturvedi G, Ding YS., 1996
Wirkmechanismus von Methylphenidat
Krause KH, Dresel S, Krause J., 2001
Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate.
Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS., Neurology 30(5), 1980
PMID: 6768005
Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine.
Zaczek R, Battaglia G, Contrera JF, Culp S, De Souza EB., Toxicol. Appl. Pharmacol. 100(2), 1989
PMID: 2551071
Methylphenidate and brain dopamine neurotoxicity.
Yuan J, McCann U, Ricaurte G., Brain Res. 767(1), 1997
PMID: 9365033
Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.
Moll GH, Hause S, Ruther E, Rothenberger A, Huether G., J Child Adolesc Psychopharmacol 11(1), 2001
PMID: 11322741
Stimulants and the developing brain.
Andersen SL., Trends Pharmacol. Sci. 26(5), 2005
PMID: 15860370
Effects of chronic reserpine treatment on development of maturity of the putamen in fetal rabbits.
Tennyson VM, Budininkas-Schoenebeck M, Gershon P., Brain Res. Bull. 9(1-6), 1982
PMID: 7172040
Neurotransmitters as morphogens.
Lauder JM., Prog. Brain Res. 73(), 1988
PMID: 2901778
Neurotransmitters in the regulation of neuronal cytoarchitecture.
Mattson MP., Brain Res. 472(2), 1988
PMID: 2898278
Neuronal degeneration and reorganization: a mutual principle in pathological and in healthy interactions of limbic and prefrontal circuits.
Teuchert-Noodt G., J. Neural Transm. Suppl. (60), 2000
PMID: 11205150
Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology.
Whitaker-Azmitia PM, Murphy R, Azmitia EC., Brain Res. 528(1), 1990
PMID: 2245332
Forty minutes of experience increase the weight and RNA content of cerebral cortex in periadolescent rats.
Ferchmin PA, Eterovic VA., Dev Psychobiol 19(6), 1986
PMID: 2433174
Social environment alters both ontogeny of dopamine innervation of the medial prefrontal cortex and maturation of working memory in gerbils (Meriones unguiculatus).
Winterfeld KT, Teuchert-Noodt G, Dawirs RR., J. Neurosci. Res. 52(2), 1998
PMID: 9579410
Effects of Enriched and of Restricted Rearing on Both Neurogenesis and Synaptogenesis in the Hippocampal Dentate Gyrus of Adult Gerbils (Meriones unguiculatus)
Keller A, Bagorda F, Hildebrandt K, Teuchert-Noodt G., 2000
Maternal care, hippocampal synaptogenesis and cognitive development in rats.
Liu D, Diorio J, Day JC, Francis DD, Meaney MJ., Nat. Neurosci. 3(8), 2000
PMID: 10903573
Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats.
Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A., Eur. J. Neurosci. 19(7), 2004
PMID: 15078560
A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system.
Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG., Behav. Brain Res. 130(1-2), 2002
PMID: 11864732

Grund T., 2005
Oral Methylphenidate During Prepuberty Prevents Pharmacologically-Induced (Preweaning) Suppressive Development of Dopamine Projections into Prefrontal Cortex and Amygdala
Grund T, Teuchert-Noodt G, Busche A, Neddens J, Moll GH, Dawirs RR., 2005
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM., Am J Psychiatry 156(8), 1999
PMID: 10450262
Association of attention-deficit disorder and the dopamine transporter gene.
Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL., Am. J. Hum. Genet. 56(4), 1995
PMID: 7717410
Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M., Mol. Psychiatry 2(4), 1997
PMID: 9246671
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes.
Castellanos FX, Tannock R., Nat. Rev. Neurosci. 3(8), 2002
PMID: 12154363
A genomewide scan for loci involved in attention-deficit/hyperactivity disorder.
Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL., Am. J. Hum. Genet. 70(5), 2002
PMID: 11923911
Dopamine transporter density in patients with attention deficit hyperactivity disorder.
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ., Lancet 354(9196), 1999
PMID: 10609822
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K., Neurosci. Lett. 285(2), 2000
PMID: 10793238
Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD., Eur. J. Nucl. Med. Mol. Imaging 30(2), 2002
PMID: 12552351
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.
Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM., J. Neurosci. 18(15), 1998
PMID: 9671677
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW., Neuropsychopharmacology 27(5), 2002
PMID: 12431845
Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex.
Marsteller DA, Gerasimov MR, Schiffer WK, Geiger JM, Barnett CR, Schaich Borg J, Scott S, Ceccarelli J, Volkow ND, Molina PE, Alexoff DL, Dewey SL., Neuropsychopharmacology 27(2), 2002
PMID: 12093590
Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX., J. Pharmacol. Exp. Ther. 245(3), 1988
PMID: 3385641
Differential expression of autoreceptors in the ascending dopamine systems of the human brain.
Meador-Woodruff JH, Damask SP, Watson SJ Jr., Proc. Natl. Acad. Sci. U.S.A. 91(17), 1994
PMID: 7914704
Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.
Coulter CL, Happe HK, Bergman DA, Murrin LC., Brain Res. 690(2), 1995
PMID: 8535839
Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.
Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI., J. Neurosci. 18(7), 1998
PMID: 9502827
Dopamine reuptake by norepinephrine neurons: exception or rule?
Carboni E, Silvagni A., Crit Rev Neurobiol 16(1-2), 2004
PMID: 15581407
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain
Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L., 2001
Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.
Grace AA., J. Neural Transm. Gen. Sect. 91(2-3), 1993
PMID: 8099795
Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis.
Seeman P, Madras B., Behav. Brain Res. 130(1-2), 2002
PMID: 11864721
Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results.
Gittelman-Klein R, Klein DF, Katz S, Saraf K, Pollack E., Arch. Gen. Psychiatry 33(10), 1976
PMID: 971031
Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity.
Weizman A, Weitz R, Szekely GA, Tyano S, Belmaker RH., J Am Acad Child Psychiatry 23(3), 1984
PMID: 6145738
Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study.
Levy F, Hay DA, McStephen M, Wood C, Waldman I., J Am Acad Child Adolesc Psychiatry 36(6), 1997
PMID: 9183127
Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat.
Pycock CJ, Carter CJ, Kerwin RW., J. Neurochem. 34(1), 1980
PMID: 6161214
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress.
Deutch AY, Clark WA, Roth RH., Brain Res. 521(1-2), 1990
PMID: 2119850
Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus.
Jaskiw GE, Weinberger DR, Crawley JN., Biol. Psychiatry 29(7), 1991
PMID: 1711381
Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli.
Mitchell JB, Gratton A., J. Neurosci. 12(9), 1992
PMID: 1527600
Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY., Neuroscience 48(4), 1992
PMID: 1352864
Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats.
Doherty MD, Gratton A., Brain Res. 715(1-2), 1996
PMID: 8739626
Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils ( Meriones unguiculatus).
Busche A, Polascheck D, Lesting J, Neddens J, Teuchert-Noodt G., J Neural Transm (Vienna) 111(4), 2004
PMID: 15057515
Connectivity of the rat amygdaloid complex
Pitkanen A., 2000
Involvement of mesocorticolimbic dopaminergic systems in emotional states.
Bertolucci-D'Angio M, Serrano A, Driscoll P, Scatton B., Prog. Brain Res. 85(), 1990
PMID: 2094907
Extinction of emotional learning: contribution of medial prefrontal cortex.
Morgan MA, Romanski LM, LeDoux JE., Neurosci. Lett. 163(1), 1993
PMID: 8295722
Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.
Rosenkranz JA, Grace AA., J. Neurosci. 21(11), 2001
PMID: 11356897
Animal models of attention-deficit hyperactivity disorder.
Davids E, Zhang K, Tarazi FI, Baldessarini RJ., Brain Res. Brain Res. Rev. 42(1), 2003
PMID: 12668288
Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell VA., Neurosci Biobehav Rev 27(7), 2003
PMID: 14624811
Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).
Sagvolden T., Neurosci Biobehav Rev 24(1), 2000
PMID: 10654658
Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J., Brain Res. 676(2), 1995
PMID: 7614004
Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis.
Kirouac GJ, Ganguly PK., Neuroscience 52(1), 1993
PMID: 8433803
Brain dopamine transporter in spontaneously hypertensive rats.
Watanabe Y, Fujita M, Ito Y, Okada T, Kusuoka H, Nishimura T., J. Nucl. Med. 38(3), 1997
PMID: 9074541
Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD.
Carey MP, Diewald LM, Esposito FJ, Pellicano MP, Gironi Carnevale UA, Sergeant JA, Papa M, Sadile AG., Behav. Brain Res. 94(1), 1998
PMID: 9708848
Psychiatric diagnoses of maltreated children: preliminary findings.
Famularo R, Kinscherff R, Fenton T., J Am Acad Child Adolesc Psychiatry 31(5), 1992
PMID: 1400118
Ontogeny of PFC-related behaviours is sensitive to a single non-invasive dose of methamphetamine in neonatal gerbils (Meriones unguiculatus).
Dawirs RR, Teuchert-Noodt G, Czaniera R., J Neural Transm (Vienna) 103(11), 1996
PMID: 9013410

Polascheck D., 2004
The postnatal maturation of dopamine innervation in the prefrontal cortex of gerbils (Meriones unguiculatus) is sensitive to an early single dose of methamphetamine. A quantitative immunocytochemical study
Dawirs RR, Teuchert-Noodt G, Czaniera R., 1994
An early methamphetamine challenge suppresses the maturation of dopamine fibres in the nucleus accumbens of gerbils: on the significance of rearing conditions.
Neddens J, Lesting J, Dawirs RR, Teuchert-Noodt G., J Neural Transm (Vienna) 109(2), 2002
PMID: 12075854
Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils: interaction of rearing conditions and early methamphetamine challenge.
Neddens J, Bagorda F, Busche A, Horstmann S, Moll GH, Dawirs RR, Teuchert-Noodt G., Brain Res. Dev. Brain Res. 146(1-2), 2003
PMID: 14643018
The acetylcholine fiber density of the neocortex is altered by isolated rearing and early methamphetamine intoxication in rodents.
Lehmann K, Hundsdorfer B, Hartmann T, Teuchert-Noodt G., Exp. Neurol. 189(1), 2004
PMID: 15296843
Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.
Puumala T, Ruotsalainen S, Jakala P, Koivisto E, Riekkinen P Jr, Sirvio J., Neurobiol Learn Mem 66(2), 1996
PMID: 8946412
Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.
Arnsten AF, Dudley AG., Behav Brain Funct 1(1), 2005
PMID: 15916700
[Memory functions in children with attention deficit/hyperactivity disorder--the effects of methylphenidate on them].
Kitazawa S, Hirabayashi S, Kobayashi M., No To Hattatsu 36(1), 2004
PMID: 14737861

Barkley RA., 1990
The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
Pliszka SR., Biol. Psychiatry 57(11), 2005
PMID: 15950012
Kann Ritalin (Methylphenidat) die Schulleistungen von Schülern mit Aufmerksamkeits- und Hyperaktivitätsproblemen verbessern? – Ein Literaturüberblick auf der Basis US-amerikanischer Forschung
Walter J., 2001
Ritalin und Schulleistungen bei HKS: Befunde bei Langfrist- und Kombinationsbehandlungen
Walter J., 2001
Offer and demand: proliferation and survival of neurons in the dentate gyrus.
Lehmann K, Butz M, Teuchert-Noodt G., Eur. J. Neurosci. 21(12), 2005
PMID: 16026459
Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.
Rapoport JL, Inoff-Germain G., J Atten Disord 6 Suppl 1(), 2002
PMID: 12685519
Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.
Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ., Science 199(4328), 1978
PMID: 341313
Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.
Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ., Arch. Gen. Psychiatry 37(8), 1980
PMID: 7406657
Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.
Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD., Proc. Natl. Acad. Sci. U.S.A. 95(24), 1998
PMID: 9826728
Effects of methylphenidate on spatial working memory and planning in healthy young adults.
Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW., Psychopharmacology (Berl.) 131(2), 1997
PMID: 9201809
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.
Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW., J. Neurosci. 20(6), 2000
PMID: 10704519
Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder.
Moll GH, Heinrich H, Rothenberger A., Acta Psychiatr Scand 107(1), 2003
PMID: 12558545
Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.
Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M., J Am Acad Child Adolesc Psychiatry 34(8), 1995
PMID: 7665441
Strain differences in the behavioral responses of male rats to chronically administered methylphenidate.
Yang PB, Amini B, Swann AC, Dafny N., Brain Res. 971(2), 2003
PMID: 12706230
Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine.
Yang PB, Swann AC, Dafny N., Life Sci. 73(22), 2003
PMID: 14511774
Altered responsiveness to cocaine in rats exposed to methylphenidate during development.
Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr., Nat. Neurosci. 5(1), 2002
PMID: 11731802
Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood.
Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ., Biol. Psychiatry 54(12), 2003
PMID: 14675795
Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder
Biederman J, Wilens T, Mick E, Spencer T, Faraone SV., 1999
Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies.
Huss M, Lehmkuhl U., J Atten Disord 6 Suppl 1(), 2002
PMID: 12685521
Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons.
Brandon CL, Marinelli M, White FJ., Biol. Psychiatry 54(12), 2003
PMID: 14675797
Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
Kuczenski R, Segal DS., Psychopharmacology (Berl.) 147(1), 1999
PMID: 10591874
Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study.
Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL., J. Pharmacol. Exp. Ther. 295(1), 2000
PMID: 10991960
Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.
Kuczenski R, Segal DS., J. Neurosci. 22(16), 2002
PMID: 12177221
Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Ruther E, Huether G., Brain Res. Dev. Brain Res. 119(2), 2000
PMID: 10675775
Hemisphere-specific effects on serotonin but not dopamine innervation in the nucleus accumbens of gerbils caused by isolated rearing and a single early methamphetamine challenge.
Lesting J, Neddens J, Busche A, Teuchert-Noodt G., Brain Res. 1035(2), 2005
PMID: 15722056
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
Volkow ND, Swanson JM., Am J Psychiatry 160(11), 2003
PMID: 14594733
Serum and brain concentrations of methylphenidate: implications for use and abuse.
Swanson JM, Volkow ND., Neurosci Biobehav Rev 27(7), 2003
PMID: 14624806
Metabolism and disposition of methylphenidate-14C: studies in man and animals.
Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA, Dayton PG., J. Pharmacol. Exp. Ther. 191(3), 1974
PMID: 4473537
Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.
Swanson JM, Volkow ND., Behav. Brain Res. 130(1-2), 2002
PMID: 11864720
Relapse to drug-seeking: neural and molecular mechanisms.
Self DW, Nestler EJ., Drug Alcohol Depend 51(1-2), 1998
PMID: 9716929
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
Charach A, Ickowicz A, Schachar R., J Am Acad Child Adolesc Psychiatry 43(5), 2004
PMID: 15100562
Altered neural substrates of cognitive control in childhood ADHD: evidence from functional magnetic resonance imaging.
Vaidya CJ, Bunge SA, Dudukovic NM, Zalecki CA, Elliott GR, Gabrieli JD., Am J Psychiatry 162(9), 2005
PMID: 16135618
Excitatory responses evoked in prefrontal cortex by mediodorsal thalamic nucleus stimulation: influence of anaesthesia.
Pirot S, Glowinski J, Thierry AM., Eur. J. Pharmacol. 285(1), 1995
PMID: 8846810
Mediodorsal thalamic evoked responses in the rat prefrontal cortex: influence of the mesocortical DA system.
Pirot S, Glowinski J, Thierry AM., Neuroreport 7(8), 1996
PMID: 8856693
Gating of information flow within the limbic system and the pathophysiology of schizophrenia.
Grace AA., Brain Res. Brain Res. Rev. 31(2-3), 2000
PMID: 10719160
Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo.
Rosenkranz JA, Grace AA., J. Neurosci. 22(1), 2002
PMID: 11756516
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Quellen

PMID: 16403217
PubMed | Europe PMC

Suchen in

Google Scholar